[Patentpractice] Freaking Ridiculous: Proposed changes to terminal disclaimer practice to promote innovation and competition

Fri May 10 16:26:50 UTC 2024

BRILLIANT!

Suzannah K. Sundby<http://www.linkedin.com/in/ssundby/> | Partner
canady + lortz LLP<http://www.canadylortz.com/>
1050 30th Street, NW
Washington, DC 20007
T: 202.486.8020
F: 202.540.8020
suzannah at canadylortz.com<mailto:suzannah at canadylortz.com>
www.canadylortz.com<http://www.canadylortz.com/>
Confidentiality Notice:  This message is being sent by or on behalf of a lawyer.  It is intended exclusively for the individual or entity to which it is addressed.  This communication may contain information that is proprietary, privileged or confidential, or otherwise legally exempt from disclosure.  If you are not the named addressee, you may not read, print, retain, copy, or disseminate this message or any part.  If you have received this message in error, please notify the sender immediately by e-mail and delete all copies of the message.

From: Patentpractice <patentpractice-bounces at oppedahl-lists.com> On Behalf Of Roger Browdy via Patentpractice
Sent: Friday, May 10, 2024 12:21 PM
To: For patent practitioners. This is not for laypersons to seek legal advice. <patentpractice at oppedahl-lists.com>
Cc: Roger Browdy <RLBrowdy at browdyneimark.com>
Subject: Re: [Patentpractice] Freaking Ridiculous: Proposed changes to terminal disclaimer practice to promote innovation and competition

Why don’t they just propose a rule that we must sign a form when filing a new application saying that we agree that if any claim of the application is found unpatentable, we agree that all claims are unpatentable.

From: Patentpractice <patentpractice-bounces at oppedahl-lists.com<mailto:patentpractice-bounces at oppedahl-lists.com>> On Behalf Of Tim Ackermann via Patentpractice
Sent: Friday, May 10, 2024 11:08 AM
To: For patent practitioners. This is not for laypersons to seek legal advice. <patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>>
Cc: Tim Ackermann <tim at ackermannlaw.com<mailto:tim at ackermannlaw.com>>
Subject: Re: [Patentpractice] Freaking Ridiculous: Proposed changes to terminal disclaimer practice to promote innovation and competition

This is the part that's (especially?) ludicrous:
    -- the Regulatory Flexibility Analysis assumes that making a decision about a Terminal Disclaimer is a decision that can be made instantaneously, at zero time, at zero cost, and the cost is just filing out the form, paying the fee, and filing.  The RegFlex analysis assumes that this change to Terminal Disclaimers will impose no additional cost of analysis, ....
So ... the rule change would mean that taking the Terminal Disclaimer would subject all of the new (application) claims to unenforceability if ANY claim in the tied patent were invalidated -- regardless of any similarity or dissimilarity of the claims. And the assertion is that no additional analysis would be needed in advising a client on taking the Terminal Disclaimer route?
 Just completely divorced from reality.
Tim Ackermann
The Ackermann Law Firm

E:  tim at ackermannlaw.com<mailto:tim at ackermannlaw.com>
P:  817.305.0690
F:  214.453.0810
W: ackermannlaw.com<http://ackermannlaw.com>
O: 1701 W. Northwest Hwy. Ste. 100
     Grapevine TX 76051

On Thu, May 9, 2024 at 5:53 PM David Boundy via Patentpractice <patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>> wrote:
Bingo.
    -- this is clearly substantive.   Beyond PTO's authority.  Not within good faith judgment call.
    -- the claim of "procedural" is false.  Utterly false.  Beyond any good faith judgment call.
    -- claim to have Paperwork Reduction Act clearance is plainly false.  Again, beyond any good faith judgment call.
    -- claim to "not significant" for Executive Order 12866.  Beyond any good faith judgment call.
    -- the Regulatory Flexibility Analysis assumes that making a decision about a Terminal Disclaimer is a decision that can be made instantaneously, at zero time, at zero cost, and the cost is just filing out the form, paying the fee, and filing.  The RegFlex analysis assumes that this change to Terminal Disclaimers will impose no additional cost of analysis, and that the resultant loss of patent value is zero.  Beyond good faith judgment call.

Kathi Vidal, your staff are lying their asses off, and you signed off on it.

On Thu, May 9, 2024 at 4:34 PM steve--- via Patentpractice <patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>> wrote:
Since the origin of the OTDP Rejection is judicial, is this simply an extrastatutory administrative over-reach?

What authority does the USPTO have to make new substantive rules outside of (a) implementing statutes and (b) ensuring compliance with extrastatutory judicial tinkering with the patent system?

Very truly yours,

Steven M. Hoffberg
Hoffberg & Associates
steve at hoffberglaw.com<mailto:steve at hoffberglaw.com>
https://www.linkedin.com/in/hoffberg/

From: Patentpractice <patentpractice-bounces at oppedahl-lists.com<mailto:patentpractice-bounces at oppedahl-lists.com>> On Behalf Of Scott Nielson via Patentpractice
Sent: Thursday, May 9, 2024 3:13 PM
To: For patent practitioners. This is not for laypersons to seek legal advice. <patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>>
Cc: Scott Nielson <scnielson at outlook.com<mailto:scnielson at outlook.com>>
Subject: Re: [Patentpractice] Freaking Ridiculous: Proposed changes to terminal disclaimer practice to promote innovation and competition

This seems targeted at drug patents and lowering the cost of drugs. It also seems that this will encourage more junk restriction requirements because applicants will be more accepting of junk restriction requirements and, consequently, examiners will be able to successfully issue junk restriction requirements more often (thereby making it easier for examiners to get counts).

Scott Nielson

801-660-4400

________________________________
From: Patentpractice <patentpractice-bounces at oppedahl-lists.com<mailto:patentpractice-bounces at oppedahl-lists.com>> on behalf of Randall Svihla via Patentpractice <patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>>
Sent: Thursday, May 9, 2024 12:31 PM
To: For patent practitioners. This is not for laypersons to seek legal advice. <patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>>
Cc: Randall Svihla <rsvihla at nsiplaw.com<mailto:rsvihla at nsiplaw.com>>
Subject: Re: [Patentpractice] Freaking Ridiculous: Proposed changes to terminal disclaimer practice to promote innovation and competition

I haven't fully analyzed the effect of this, but my initial reaction is that it SUUUUUUUUUUUCKS.

If they do this, they need to shut down the office for a month and retrain the Examiners on how to make a proper nonstatutory double patenting rejection.  Most of the rejections they issue now are completely BOGUS.

Best regards,

Randall S. Svihla

NSIP Law

Washington, D.C.

From: Patentpractice <patentpractice-bounces at oppedahl-lists.com<mailto:patentpractice-bounces at oppedahl-lists.com>> On Behalf Of Suzannah K. Sundby via Patentpractice
Sent: Thursday, May 9, 2024 2:22 PM
To: patentpractice at oppedahl-lists.com<mailto:patentpractice at oppedahl-lists.com>
Cc: Suzannah K. Sundby <suzannah at canadylortz.com<mailto:suzannah at canadylortz.com>>
Subject: [Patentpractice] Freaking Ridiculous: Proposed changes to terminal disclaimer practice to promote innovation and competition

This is so freaking ridiculous.

It’s an attempt to limit continuations and prevent/reduce patents… basically what Dudas tried to do with continuation practice…

Suzannah K. Sundby<http://www.linkedin.com/in/ssundby/> | Partner

canady + lortz LLP<http://www.canadylortz.com/>

1050 30th Street, NW

Washington, DC 20007

T: 202.486.8020

F: 202.540.8020

suzannah at canadylortz.com<mailto:suzannah at canadylortz.com>

www.canadylortz.com<http://www.canadylortz.com/>

Confidentiality Notice:  This message is being sent by or on behalf of a lawyer.  It is intended exclusively for the individual or entity to which it is addressed.  This communication may contain information that is proprietary, privileged or confidential, or otherwise legally exempt from disclosure.  If you are not the named addressee, you may not read, print, retain, copy, or disseminate this message or any part.  If you have received this message in error, please notify the sender immediately by e-mail and delete all copies of the message.

From: U.S. Patent and Trademark Office <subscriptioncenter at subscriptions.uspto.gov<mailto:subscriptioncenter at subscriptions.uspto.gov>>
Sent: Thursday, May 9, 2024 2:17 PM
To: Suzannah K. Sundby <suzannah at canadylortz.com<mailto:suzannah at canadylortz.com>>
Subject: Proposed changes to terminal disclaimer practice to promote innovation and competition

The USPTO has issued a notice of proposed rulemaking (NPRM) to add a new requirement for terminal disclaimers.

Having trouble viewing this email? View it as a Web page<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDAsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vY29udGVudC5nb3ZkZWxpdmVyeS5jb20vYWNjb3VudHMvVVNQVE8vYnVsbGV0aW5zLzM5YjgzMjYiLCJidWxsZXRpbl9pZCI6IjIwMjQwNTA5Ljk0NTY1OTIxIn0.EyMw7a2q5wF5cdpvZJUCX1wdqcG-VKQvfp7Ug9tWBsI/s/1514988646/br/242170303451-l>.

[Image removed by sender.]

News Brief

[Image removed by sender. US Patent and Trademark Office]

Proposed changes to terminal disclaimer practice to promote innovation and competition

The United States Patent and Trademark Office (USPTO) has issued a notice of proposed rulemaking (NPRM) to add a new requirement for terminal disclaimers filed to obviate (overcome) nonstatutory double patenting.

Under U.S. law, an inventor, patent owner or joint researchers may obtain more than one patent with claims that vary in only minor (patentably indistinct) ways from each other. The USPTO will reject such claims under “obviousness-type double patenting” (also known as “nonstatutory double patenting”) and will allow claims to issue only as long as the practice of obtaining similar claims across patents isn’t used to extend the patent exclusivity term or allow multiple parties to harass an alleged infringer. Both conditions aim to strike a balance between incentivizing innovation in the first instance while providing more certainty to competitors and the public.

The proposed rule responds to public feedback and proposes to add a third condition that would further promote innovation and competition by reducing the cost of separately challenging each patent in a group of multiple patents directed to indistinct variations of a single invention. Under the proposed rule, to overcome double patenting the patentee would need to agree that the patent with the terminal disclaimer will be enforceable only if the patent is not tied and has never been tied through one or more terminal disclaimers to a patent in which any claim has been finally held unpatentable or invalid over prior art. In addition to reducing costs, the proposed rule is expected to streamline and expedite patent disputes, narrow validity issues, and provide greater certainty to competitors and to the public. The proposed rule is prospective in nature and would apply to terminal disclaimers filed on or after the effective date of any final rule.

The USPTO recognizes that, as with any proposed rule change, patentees will need to consider and potentially adapt their practices. While the USPTO moves forward with rulemaking, the Office is considering ways the Office can support stakeholders. Comments on the proposed rule, as well as comments on USPTO practice as related to the proposed rule, are welcome.

“Our mission at the USPTO is to drive U.S. innovation and global competitiveness for the benefit of all Americans,” said Under Secretary of Commerce and Director of the USPTO Kathi Vidal. “This proposed rule is part of a holistic, thoughtful and balanced approach to bolstering our strong intellectual property system. We must remain steadfast in incentivizing and protecting the investments in innovation that drive U.S. leadership, while recognizing that surgical changes can create efficiencies that reduce costs and promote competition.”

The full text of the notice is available at the Federal Register<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vd3d3LmZlZGVyYWxyZWdpc3Rlci5nb3YvcHVibGljLWluc3BlY3Rpb24vMjAyNC0xMDE2Ni90ZXJtaW5hbC1kaXNjbGFpbWVyLXByYWN0aWNlLXRvLW9idmlhdGUtbm9uc3RhdHV0b3J5LWRvdWJsZS1wYXRlbnRpbmc_dXRtX2NhbXBhaWduPXN1YnNjcmlwdGlvbmNlbnRlciZ1dG1fY29udGVudD0mdXRtX21lZGl1bT1lbWFpbCZ1dG1fbmFtZT0mdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSZ1dG1fdGVybT0iLCJidWxsZXRpbl9pZCI6IjIwMjQwNTA5Ljk0NTY1OTIxIn0.Ri4CT8s3uXvsmWzgIT6enHV9Hrhc7nCW0h1JVCsMOuc/s/1514988646/br/242170303451-l> and on the USPTO’s Patent Related Notices webpage<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDIsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vd3d3LnVzcHRvLmdvdi9wYXRlbnRzL2xhd3MvcGF0ZW50LXJlbGF0ZWQtbm90aWNlcy9wYXRlbnQtcmVsYXRlZC1ub3RpY2VzLTIwMjQ_dXRtX2NhbXBhaWduPXN1YnNjcmlwdGlvbmNlbnRlciZ1dG1fY29udGVudD0mdXRtX21lZGl1bT1lbWFpbCZ1dG1fbmFtZT0mdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSZ1dG1fdGVybT0iLCJidWxsZXRpbl9pZCI6IjIwMjQwNTA5Ljk0NTY1OTIxIn0.BHMm-eKtJM5AEEgPIU_ronUBHxMEOnDJBZwwTU31SWE/s/1514988646/br/242170303451-l>. You must submit comments on the NPRM by July 9, through the Federal eRulemaking Portal<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDMsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly93d3cucmVndWxhdGlvbnMuZ292Lz91dG1fY2FtcGFpZ249c3Vic2NyaXB0aW9uY2VudGVyJnV0bV9jb250ZW50PSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9uYW1lPSZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5JnV0bV90ZXJtPSIsImJ1bGxldGluX2lkIjoiMjAyNDA1MDkuOTQ1NjU5MjEifQ.x9j7p6cIgsa045JjXz-sdsiE29sQzlCXLIFpUp-XoHI/s/1514988646/br/242170303451-l>, to ensure consideration.

[Image removed by sender. facebook]<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDQsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly93d3cuZmFjZWJvb2suY29tL3VzcHRvLmdvdj91dG1fY2FtcGFpZ249c3Vic2NyaXB0aW9uY2VudGVyJnV0bV9jb250ZW50PSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9uYW1lPSZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5JnV0bV90ZXJtPSIsImJ1bGxldGluX2lkIjoiMjAyNDA1MDkuOTQ1NjU5MjEifQ.fH0fSL2ws41jjEZJDkcXyFBqY7MgF_wKvhR9Kg1lqyY/s/1514988646/br/242170303451-l>[Image removed by sender. twitter]<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDUsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly90d2l0dGVyLmNvbS91c3B0bz91dG1fY2FtcGFpZ249c3Vic2NyaXB0aW9uY2VudGVyJnV0bV9jb250ZW50PSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9uYW1lPSZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5JnV0bV90ZXJtPSIsImJ1bGxldGluX2lkIjoiMjAyNDA1MDkuOTQ1NjU5MjEifQ.ERGJlAzu-mDkmaOLtrxv3trpYrhONs040tPKshlLDb4/s/1514988646/br/242170303451-l>[Image removed by sender. youtube]<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDYsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly95b3V0dWJlLmNvbS91c3B0b3ZpZGVvP3V0bV9jYW1wYWlnbj1zdWJzY3JpcHRpb25jZW50ZXImdXRtX2NvbnRlbnQ9JnV0bV9tZWRpdW09ZW1haWwmdXRtX25hbWU9JnV0bV9zb3VyY2U9Z292ZGVsaXZlcnkmdXRtX3Rlcm09IiwiYnVsbGV0aW5faWQiOiIyMDI0MDUwOS45NDU2NTkyMSJ9.-gDJBXUYZbKuG-IitNkIPqSp-6BJjJezp2-gojWk5OE/s/1514988646/br/242170303451-l>[Image removed by sender. linkedin]<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDcsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly9saW5rZWRpbi5jb20vY29tcGFueS91c3B0bz91dG1fY2FtcGFpZ249c3Vic2NyaXB0aW9uY2VudGVyJnV0bV9jb250ZW50PSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9uYW1lPSZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5JnV0bV90ZXJtPSIsImJ1bGxldGluX2lkIjoiMjAyNDA1MDkuOTQ1NjU5MjEifQ.EEelCFc6-31zAhzs3KmPABfl-XSa77Qmebb1e4EoEEM/s/1514988646/br/242170303451-l>

Stay connected with the USPTO by subscribing to regular email updates.

Visit our subscription center at www.uspto.gov/subscribe<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDgsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly93d3cudXNwdG8uZ292L3N1YnNjcmliZT91dG1fY2FtcGFpZ249c3Vic2NyaXB0aW9uY2VudGVyJnV0bV9jb250ZW50PSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9uYW1lPSZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5JnV0bV90ZXJtPSIsImJ1bGxldGluX2lkIjoiMjAyNDA1MDkuOTQ1NjU5MjEifQ.2LLW5PzXqTN2R7qdhXdjG7E8XqGpa5-6SYx3u8cFSNc/s/1514988646/br/242170303451-l> to update or change your email preferences.

This email was sent from an unmonitored mailbox. To contact us, please visit our website www.uspto.gov/about/contacts<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDksInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHA6Ly93d3cudXNwdG8uZ292L2Fib3V0L2NvbnRhY3RzP3V0bV9jYW1wYWlnbj1zdWJzY3JpcHRpb25jZW50ZXImdXRtX2NvbnRlbnQ9JnV0bV9tZWRpdW09ZW1haWwmdXRtX25hbWU9JnV0bV9zb3VyY2U9Z292ZGVsaXZlcnkmdXRtX3Rlcm09IiwiYnVsbGV0aW5faWQiOiIyMDI0MDUwOS45NDU2NTkyMSJ9.fq8UjH1xTrq8PBocQEDrT5pDcB7lpe37p1ptWbQZ3g4/s/1514988646/br/242170303451-l>. To ensure that you continue to receive our news and notices, please modify your email filters to allow mail from subscriptioncenter at subscriptions.uspto.gov<mailto:subscriptioncenter at subscriptions.uspto.gov>.

[Image removed by sender.]

________________________________

This email was sent to suzannah at canadylortz.com<mailto:suzannah at canadylortz.com> using GovDelivery Communications Cloud on behalf of: United States Patent and Trademark Office ·600 Dulany Street · Alexandria , VA 22314

[Image removed by sender. GovDelivery logo]<https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMTAsInVyaSI6ImJwMjpjbGljayIsInVybCI6Imh0dHBzOi8vc3Vic2NyaWJlcmhlbHAuZ3JhbmljdXMuY29tLz91dG1fY2FtcGFpZ249c3Vic2NyaXB0aW9uY2VudGVyJnV0bV9jb250ZW50PSZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9uYW1lPSZ1dG1fc291cmNlPWdvdmRlbGl2ZXJ5JnV0bV90ZXJtPSIsImJ1bGxldGluX2lkIjoiMjAyNDA1MDkuOTQ1NjU5MjEifQ.w5UH5_d9De1PY98UTXnxxrAgGQEQfnARCnnHUAVmsVU/s/1514988646/br/242170303451-l>

[https://s-install.avcdn.net/ipm/preview/icons/icon-envelope-tick-round-orange-animated-no-repeat-v1.gif]<https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=emailclient>
Virus-free.www.avast.com<https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaign=sig-email&utm_content=emailclient>
--
Patentpractice mailing list
Patentpractice at oppedahl-lists.com<mailto:Patentpractice at oppedahl-lists.com>
http://oppedahl-lists.com/mailman/listinfo/patentpractice_oppedahl-lists.com

--

[https://ci3.googleusercontent.com/mail-sig/AIorK4wRMgBgcdZCqTw68Gg6ihENvW6_y8dGBqYvnJwiaIyu6LO5a7IJ-cljKsueIE5uxXbT6s9MN5hE2lGU]
<https://www.iam-media.com/strategy300/individuals/david-boundy>

David Boundy | Partner | Potomac Law Group, PLLC

P.O. Box 590638, Newton, MA  02459

Tel (646) 472-9737 | Fax: (202) 318-7707

dboundy at potomaclaw.com<mailto:dboundy at potomaclaw.com> | www.potomaclaw.com<http://www.potomaclaw.com>

Articles at http://ssrn.com/author=2936470<http://ssrn.com/author=2936470>
<https://www.keynect.us/requestCardAccess/USA500DBOUN?>

Click here to add me to your contacts.<https://www.keynect.us/requestCardAccess/USA500DBOUN?>
--
Patentpractice mailing list
Patentpractice at oppedahl-lists.com<mailto:Patentpractice at oppedahl-lists.com>
http://oppedahl-lists.com/mailman/listinfo/patentpractice_oppedahl-lists.com
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://oppedahl-lists.com/pipermail/patentpractice_oppedahl-lists.com/attachments/20240510/88a58bcd/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.jpg
Type: image/jpeg
Size: 823 bytes
Desc: image001.jpg
URL: <http://oppedahl-lists.com/pipermail/patentpractice_oppedahl-lists.com/attachments/20240510/88a58bcd/attachment.jpg>